State of New Jersey Common Pension Fund D cut its holdings in QCR Holdings, Inc. (NASDAQ:QCRH – Free Report) by 20.0% in the 3rd quarter, according to its most recent 13F filing with the SEC. The firm owned 25,858 shares of the bank’s stock after selling 6,459 shares during the period. State of New Jersey Common Pension Fund D owned about 0.15% of QCR worth $1,914,000 as of its most recent filing with the SEC.
Several other hedge funds and other institutional investors have also modified their holdings of the business. Rhumbline Advisers boosted its holdings in shares of QCR by 1.3% in the 2nd quarter. Rhumbline Advisers now owns 26,407 shares of the bank’s stock valued at $1,584,000 after buying an additional 341 shares during the period. ClariVest Asset Management LLC boosted its stake in QCR by 2.9% during the 2nd quarter. ClariVest Asset Management LLC now owns 15,080 shares of the bank’s stock valued at $905,000 after purchasing an additional 421 shares during the period. Principal Financial Group Inc. boosted its stake in QCR by 6.6% during the 2nd quarter. Principal Financial Group Inc. now owns 7,472 shares of the bank’s stock valued at $448,000 after purchasing an additional 463 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in QCR by 12.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 4,713 shares of the bank’s stock valued at $287,000 after purchasing an additional 539 shares during the period. Finally, Innealta Capital LLC acquired a new position in QCR during the 2nd quarter valued at about $35,000. 70.01% of the stock is owned by institutional investors and hedge funds.
QCR Stock Down 1.3 %
QCRH stock opened at $89.89 on Monday. QCR Holdings, Inc. has a 52 week low of $49.47 and a 52 week high of $93.72. The company has a market capitalization of $1.52 billion, a price-to-earnings ratio of 13.05 and a beta of 0.93. The firm’s 50-day moving average is $78.71 and its two-hundred day moving average is $69.23. The company has a current ratio of 1.02, a quick ratio of 1.00 and a debt-to-equity ratio of 0.67.
QCR Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Wednesday, October 2nd. Shareholders of record on Friday, September 13th were given a dividend of $0.06 per share. The ex-dividend date was Friday, September 13th. This represents a $0.24 dividend on an annualized basis and a dividend yield of 0.27%. QCR’s dividend payout ratio (DPR) is 3.48%.
Insiders Place Their Bets
In related news, CAO Nick W. Anderson sold 675 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $81.93, for a total value of $55,302.75. Following the sale, the chief accounting officer now directly owns 782 shares in the company, valued at $64,069.26. The trade was a 46.33 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 3.70% of the stock is owned by insiders.
Analysts Set New Price Targets
Separately, Keefe, Bruyette & Woods reissued an “outperform” rating and set a $82.00 target price (up from $70.00) on shares of QCR in a research note on Monday, July 29th.
Read Our Latest Research Report on QCRH
QCR Profile
QCR Holdings, Inc, a multi-bank holding company, provides commercial and consumer banking, and trust and asset management services. The company’s deposit products include noninterest-bearing demand, interest-bearing demand, time, and brokered deposits. It also provides various commercial and retail lending/leasing, and investment services to corporations, partnerships, individuals, and government agencies.
Featured Articles
- Five stocks we like better than QCR
- Why Are These Companies Considered Blue Chips?
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- The How and Why of Investing in Gold Stocks
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- 3 Stocks to Protect Your Portfolio from the Coronavirus Contagion
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for QCR Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for QCR and related companies with MarketBeat.com's FREE daily email newsletter.